Cafepharma Today

May 30 2025 - #ASCO25 tracker: Meeting kicks off in Chicago with high expectations in breast, lung cancer
#ASCO25 tracker: Meeting kicks off in Chicago with high expectations in breast, lung cancer
Roche links BTK inhibitor to low relapse rate across 96-week multiple sclerosis trial
Mixed COPD results for Regeneron, Sanofi drug cloud approval chances
Illumina introduces a new AI algorithm PromoterAI
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

GSK investors told of crucial new drugs on the way
The Independent, UK
Sunday, November 20, 2011 - 12:20pm
tags:
GSK, open-access R&D
China’s Thirst for New Diabetes Drugs Threatens Bayer’s Lead
Bloomberg
Sunday, November 20, 2011 - 12:17pm
tags:
Bayer, Eli Lilly, Merck, Novo Nordisk, diabetes, China, Glucobay
Pushing Onwards With CETP Inhibition: What Big-Time Drug Development Is All About
Seeking Alpha
Sunday, November 20, 2011 - 12:14pm
tags:
CETP inhibitors, Merck, Roche, Eli Lilly, Anacetrapib, dalcetrapib, evacetrapib
Does Johnson & Johnson Pass Buffett's Test?
Motley Fool
Sunday, November 20, 2011 - 12:13pm
tags:
JNJ, Warren Buffett
Pfizer Cuts Lipitor Deals To Fight Generics
Seeking Alpha
Sunday, November 20, 2011 - 12:12pm
tags:
Pfizer, Lipitor, generics, Watson Pharmaceuticals
The pharmaceutical companies of India are reportedly betting high on the American Oral Contraceptive (OC) market.
India Infoline, India
Saturday, November 19, 2011 - 1:26pm
tags:
Lupin, contraceptives
Bristol-Myers Squibb Company (BMY): Today's Featured Drugs Winner
The Street
Saturday, November 19, 2011 - 1:23pm
tags:
Bristol-Myers Squibb
P&G Targets OTC Drug Market Growth with Teva JV
Trefis
Saturday, November 19, 2011 - 1:18pm
tags:
Proctor & Gamble, Teva Pharmaceuticals, OTC
Savient Pharmaceuticals down3.9%
Zacks
Saturday, November 19, 2011 - 1:16pm
tags:
Savient
Tonix Pharmaceuticals Receives FDA Clearance to Initiate a Pharmacokinetic Study of TNX-102 For Fibromyalgia
Enhanced Online News
Saturday, November 19, 2011 - 1:13pm
tags:
Tonix Pharmaceuticals, TNX-102, fibromyalgia, cyclobenzaprine
Johnson & Johnson Passes This Key Test
Motley Fool
Saturday, November 19, 2011 - 12:35pm
tags:
JNJ
AstraZeneca Releases Full SATURN Data
Yahoo/Zacks
Saturday, November 19, 2011 - 12:32pm
tags:
Pfizer, Lipitor, Crestor, atherosclerosis, AstraZeneca, SATURN
EU Approval for Pfizer Drug
Yahoo/Zacks
Saturday, November 19, 2011 - 12:20pm
tags:
Vyndaqel, Pfizer, transthyretin familial amyloid polyneuropathy
Incyte: Where Do We Go From Here?
Seeking Alpha
Saturday, November 19, 2011 - 12:15pm
tags:
Incyte
Merck's Vorapaxar Disappoints
Yahoo/Zacks
Saturday, November 19, 2011 - 12:13pm
tags:
Merck, Vorapaxar, acute coronary syndrome, anticlotting
Incyte CEO Touts Prospects of New Cancer Drug
Minyanville
Saturday, November 19, 2011 - 11:38am
tags:
Jakafi, Incyte, myelofibrosis
Regeneron Announces FDA Approval of EYLEA™ (aflibercept) Injection for the Treatment of Wet Age-Related Macular Degeneration
Yahoo/PR NewsWire
Saturday, November 19, 2011 - 11:36am
tags:
Regeneron, Eylea, macular degeneration, age-related macular degeneration
Achillion in Talks With Potential Buyers or Partners, Chief Executive Says
Bloomberg
Saturday, November 19, 2011 - 11:35am
tags:
Achillion, hepatitis C, GSK, Novartis
Amgen Says It Signed Seven-Year Epogen Sales Agreement With DaVita
Bloomberg
Saturday, November 19, 2011 - 11:33am
tags:
Amgen, DaVita, Epogen
When First-Line Drugs Don't Help, Questcor Steps In
Investor's Business Daily
Saturday, November 19, 2011 - 11:32am
tags:
Questcor Pharmaceuticals

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.